Oral ketamine therapy in the treatment of postamputation stump pain

Acta Anaesthesiol Scand
Vol 41 (No. 3) Mar 1997; 427-429
by L. Nikolajsen; P.O. Hansen; T.S. Jensen


BACKGROUND: Hyperactivity of N-methyl-D-aspartate (NMDA) receptors may be one of the factors in the maintenance of postamputation stump pain.

CASE REPORT: Ketamine-a clinical available NMDA receptor antagonist-was administered intravenously to a patient with established stump pain in a double-blind saline-controlled fashion. Following infusion stump pain was alleviated for 31 hours. Ketamine reduced the allodynic area and wind-up-like pain and increased pressure-pain thresholds. Treatment was started with ketamine 50 mg x 4 per day dissolved in juice. No side effects or development of tolerance were observed during a 3-month treatment period.

CONCLUSION: NMDA receptor antagonists may have a potential in the treatment of neuropathic pain, including stump pain.




Last Modified - Fri, Mar 31, 2006 Used by Erowid without permission of author

[ Back to Ketamine Vault ] [ Back to Journal Articles ]
[Plants & Drugs] [Mind & Spirit] [Freedom & Law] [Arts & Sciences] [Library] [Search] [About]
(html and design © 1995-2005 Erowid.org. Please ask permission before publicly reproducing.)
(Contents © respective copyright holders.)
Erowid.org Plants & Drugs Mind & Spirit Freedom & Law Arts & Sciences Search About Erowid and Feedback Library & Bookstore Copyrights Memberships